Comerica Bank reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 9.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,860 shares of the company’s stock after selling 3,248 shares during the period. Comerica Bank’s holdings in HCA Healthcare were worth $14,407,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in HCA. Cerity Partners LLC raised its position in HCA Healthcare by 13.1% in the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after acquiring an additional 5,092 shares during the period. National Pension Service raised its position in HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after acquiring an additional 17,531 shares during the period. Savant Capital LLC raised its position in HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after acquiring an additional 1,246 shares during the period. Sector Gamma AS raised its position in HCA Healthcare by 36.0% in the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after acquiring an additional 2,883 shares during the period. Finally, Nordea Investment Management AB raised its position in HCA Healthcare by 11.2% in the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after acquiring an additional 108,849 shares during the period. 62.73% of the stock is owned by institutional investors.
Insider Activity at HCA Healthcare
In other news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock worth $7,797,595 over the last quarter. 1.50% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on HCA
Key HCA Healthcare News
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Stockholders reaffirmed HCA’s board and governance at the April 23 annual meeting — removes near‑term activist/governance uncertainty and supports continuity of management strategy. HCA Healthcare Stockholders Reaffirm Board and Governance Structure
- Positive Sentiment: Management highlights improvements in revenue‑cycle performance (CFO commentary) that are contributing to margin resilience despite rising denials/underpayments — a constructive operating tailwind. HCA’s strengthened revenue cycle paying dividends, CFO says
- Neutral Sentiment: Company announced a proposed public offering of senior notes — proceeds for general corporate purposes and possible refinancing; watch pricing and size for balance‑sheet/interest‑cost implications. HCA Announces Proposed Public Offering of Senior Notes
- Neutral Sentiment: Local operational news: new $231M Florida hospital opening in May and a Gulf Coast NICU reunion — positive for regional capacity/brand but not material near‑term drivers. $231M HCA Florida hospital to open in May HCA Gulf Coast Hospital NICU reunion for patients & families
- Neutral Sentiment: Executive hire: Cynthia Cifuentes‑Finkel named SVP of Marketing & Corporate Affairs (effective June 8) — supports communications/brand, immaterial to near‑term financials. HCA Healthcare Names Cynthia Cifuentes‑Finkel SVP
- Negative Sentiment: Analysts across the street cut price targets after Q1: multiple firms lowered PTs (examples: Bernstein to $503, Oppenheimer to $520, TD Cowen/Leerink to ~$500, RBC/Truist/Stephens also trimmed). The volume of PT trims amplifies downward pressure on the stock despite several banks keeping Buy/Outperform stances. Bernstein adjusts price target on HCA
- Negative Sentiment: Policy/revenue hit: the lapse in ACA subsidy funding reduced Q1 results by about $150M — a tangible near‑term earnings drag referenced in coverage. ACA subsidy lapse cost HCA Healthcare $150M in Q1
- Negative Sentiment: Analysts trimmed forward forecasts after Q1 in several writeups (sales roughly in line but EPS slightly missed), increasing near‑term uncertainty around estimates and supporting the sell‑side PT resets. These Analysts Slash Their Forecasts On HCA Healthcare After Q1 Results
HCA Healthcare Trading Down 3.3%
Shares of NYSE HCA opened at $430.99 on Wednesday. The business has a 50-day moving average of $501.51 and a 200-day moving average of $486.12. The firm has a market capitalization of $96.36 billion, a price-to-earnings ratio of 14.82, a PEG ratio of 1.50 and a beta of 1.36. HCA Healthcare, Inc. has a 12 month low of $329.72 and a 12 month high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.HCA Healthcare’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 30.06 earnings per share for the current year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.73%.
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
